Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Asset Writedowns and Impairment: 2010-2024

Historic Asset Writedowns and Impairment for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $1.3 million.

  • Cryo Cell International's Asset Writedowns and Impairment rose 1544.09% to $413611.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $1.1 million, marking a year-over-year decrease of 1290.9%. This contributed to the annual value of $1.3 million for FY2024, which is 6609.95% down from last year.
  • As of FY2024, Cryo Cell International's Asset Writedowns and Impairment stood at $1.3 million, which was down 6609.95% from $3.7 million recorded in FY2023.
  • In the past 5 years, Cryo Cell International's Asset Writedowns and Impairment ranged from a high of $3.7 million in FY2023 and a low of $929618.0 during FY2022
  • Over the past 5 years, Cryo Cell International's median Asset Writedowns and Impairment value was $1.3 million (recorded in 2024), while the average stood at $1.7 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 30200.74% in 2023, then tumbled by 6609.95% in 2024.
  • Annual analysis of 5 years shows Cryo Cell International's Asset Writedowns and Impairment stood at $1.3 million in 2020, then fell by 9.32% to $1.2 million in 2021, then decreased by 20.17% to $929618.0 in 2022, then skyrocketed by 302.01% to $3.7 million in 2023, then plummeted by 66.1% to $1.3 million in 2024.
  • Its last three reported values are $1.3 million in FY2024, $3.7 million for FY2023, and $929618.0 during FY2022.